ReviewInternational journal of molecular sciences2018

The Therapeutic Strategy of HDAC6 Inhibitors in Lymphoproliferative Disease.

Maria Cosenza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.